Item 2.01. Completion of Acquisition or Disposition of Assets.
On December 14, 2018, BioHiTech Global, Inc. (the Registrant) consummated a transaction previously reported in the Registrants Current Report on Form 8-K filed on December 4, 2018, which disclosed that on November 28, 2018, the Registrant entered into a definitive agreement with Entsorga USA, Inc. (EUSA) whereby EUSA agreed to sell, transfer and convey to the Registrant Two Thousand Six Hundred Seventy-Six and 60/100 (2,676.60) common units of Entsorga West Virginia, LLC, a West Virginia limited liability company (EWV) in consideration for 714,519 newly issued shares of stock (the Purchase Price) of the Registrants newly created Series E Preferred Stock, par value $0.0001, (the Series E Shares) convertible into 714,539 shares (the Conversion Shares) of the Registrants common stock, par value $0.0001 per share (the Common Stock). The terms and conditions of the Series E Shares were to be set forth in the Certificate of Designation or Rights and Preferences (the Certificate of Designation) to be agreed upon by EUSA and the Registrant prior to the closing, which was anticipated to be in December 2018 and subject to customary deliverables by each of the Registrant and EUSA.
The Registrants newly created Series E Preferred Stock, par value $0.0001 per share (the Series E Shares) with a stated value of $2.64 per share is convertible into shares of the Registrants common stock, par value $0.0001 per share (the Common Stock) and does not earn any dividends and has no special voting rights. The Series E Shares are convertible at the rate of one share of Common Stock for each Series E Share converted, subject to adjustment for stock splits and reclassifications. The Series E Shares were sold to one holder (EUSA) who has the right to have the Registrant redeem any deficiency between the proceeds from the Holders sales of conversion shares resulting from the Series E Shares and $400,000 occurring through February 15, 2019. Failure to make notice of the request for redemption by February 21, 2019 provides for the expiration of the redemption right. Pursuant to the Certificate of Designation, immediately following the issuance of the Series E Shares, 150,000 Series E Shares were converted into 150,000 shares of Common Stock.
The foregoing description of the terms and conditions of the the Certificate of Designation is only a summary and is qualified in its entirety by the full text of the Certificate of Designation. For an understanding of its terms and provisions, reference should be made to the Certificate of Designation, attached this Current Report on Form 8-K as Exhibit 4.1, which is incorporated herein by reference.
On December 17, 2018, the Registrant issued a press release announcing the aforementioned agreement. A copy of the press release is attached as Exhibit 99.5 to this Current Report and is incorporated herein by reference.
